Vital Signs Monitoring Devices Market to Reach $11.55 Billion by 2027; High Usage in Neonatal Intensive Care Unit to Accelerate Growth

The global Vital Signs Monitoring Devices market size is projected to reach USD 11.55 billion by 2027. This growth is attributable to the increasing demand for these Devices from the neonatal intensive care unit (NICU) for constantly observing oxygen levels, oxygen levels, and respiratory rate in infants. Fortune Business Insights™ published this information in a recent report, titled, “Vital Signs Monitoring Devices Market Size, Share & COVID-19 Impact Analysis, By Type (Pulse-oximeters, Temperature Monitors, & Blood Pressure Monitors), By End User (Hospitals and Ambulatory Surgical Centers, Clinics, Home Care Settings and Others), and Regional Forecast, 2020-2027.” The report further states that the market size was USD 4.63 billion in 2019. It is set to exhibit a CAGR of 11.0% during the forecast period between 2020 to 2027.

Hillrom Introduces its Latest Hillrom™ Extended Care Solution

In June 2020, Hillrom, a provider of hospital beds, medical technology systems, and healthcare equipment based in Indiana, announced the launch of its latest connected remote vital signs monitoring device. It is called Hillrom™ Extended Care Solution. It uses emerging resources and programs consisting of changes in reimbursement for advancing the adoption of remote monitoring. Apart from that, the device blends an all-in-one vital signs solution to provide the clinician access to information.

As per the company officials, “This technology would help at-risk and recovering patients, including the COVID-19 positives to feel comfortable, safe, and confident at home. The medical staff can efficiently access their vital data to rapidly check the patients’ health status right from their clinics. At the same time, it would aid in lowering the utilization of critical protective gear, risk of exposure, and reducing hospital patient load.”

To get a detailed report summary and research scope of this market, click here:

https://www.fortunebusinessinsights.com/vital-signs-monitoring-devices-market-103359

Higher Adoption for Controlling COVID-19 will Skyrocket Demand

There is a rise in the prevalence of chronic diseases, such as diabetes, hypertension, obesity, and dyslipidemia across the globe owing to the increasing adoption of sedentary lifestyle. Besides, the surging demand for personalized and accurate Vital Signs Monitoring Devices would also affect the market positively in the near future.

Furthermore, the outbreak of the COVID-19 pandemic has created high demand for these devices for controlling the spread of the infection. 1mg, an online pharmaceutical company, for instance, stated that it exhibited a hike of 15 times in the sale of pulse oximeters in 2020. However, their expensive nature may hinder the Vital Signs Monitoring Devices market growth in the forthcoming years.

Key Players Aim to Unveil Novel Vital Signs Monitoring Devices to Intensify Competition

The prominent companies present in the market are persistently striving to gain a competitive edge by introducing novel Vital Signs Monitoring Devices infused with the latest technologies. They are also trying to gain fast-track approvals from the regulatory bodies to distribute their products in the market.  

Fortune Business Insights™ presents a list of all the significant manufacturers of operating in the global market. They are as follows:

• Koninklijke Philips N.V.


• Medtronic


• Nihon Kohden Corporation


• GE Healthcare


• Masimo


• Omron Healthcare


• Contec Medical Systems Co. Ltd


• A&D Company Ltd.


• Nonin Medical Inc.


• SunTech Medical, Inc.


• Other Players

A Notable Industry Development-

• December 2019: Nihon Kohden, a producer of medical electronic equipment headquartered in Japan, launched Life Scope SVM-7200 Series, its new portable vital signs monitoring tool. It possesses customizable early warning scoring. It would help the caregivers to assess patient condition promptly by combining their observational data and vital signs data.

Further Report Findings-

• In 2019, North America procured USD 2.77 billion in terms of revenue backed by the increasing cases of chronic disorders occurring because of sedentary lifestyle.


• Asia Pacific is expected to exhibit the highest CAGR in the near future on account of the rising awareness programs amongst the masses about numerous beneficial properties of these Devices.


• In terms of type, the blood pressure monitors segment generated 27.9% Vital Signs Monitoring Devices market share in 2019.

The global market can be segmented in the following way: